WEIFA ASA Oslo, 15 January 2015
Reference is made to the stock exchange release on 17 December 2015 regarding the acquisition of the outstanding shares of Cederroth AS, the company that owns the leading intimate care brand Asan and its Swedish counterpart Sana. The transaction is approved by the Competition Authorities and completed today through the final settlement of the purchase consideration.
For further information, please contact:
Kathrine Gamborg Andreassen
CEO
+47 951 78 680
kathrine.gamborg.andreassen@weifa.no
Simen Nyberg-Hansen
CFO
+47 9820 6355
simen.nyberg-hansen@weifa.no
About Weifa:
Weifa is Norway's leading Consumer health company. Weifa supplies pharmaceutical products and lifestyle products that address the essential needs of consumers, customers and professional partners. The Company has a strong position in Norway and is the market leader in pain relief, with well-established brands such as Paracet and Ibux, and is also present in other key areas such as dietary supplements and treatment for colds and respiratory problems. Weifa is listed on the Oslo Stock Exchange and has its head office in Oslo. In 2014, the Group had a turnover of approximately NOK 316m (after adjusting for the divestment of the B2B business). The company currently has approximately 30 employees.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Weifa ASA via Globenewswire
